Purpose
to develop nOPV1 using Nevoline technology to benefit infants in LMICs at risk of exposure to Polio virus
Grantee
Division
Global Health
Date
NOVEMBER 2024
Region served
GLOBAL
Committed amount
$7,822,172
Grant topic
Vaccine Development
Duration (months)
26
Grantee location
Bandung, Indonesia
Program strategy page
More about our work
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.